Zenas BioPharma, Inc. · NASDAQ:ZBIO
Zenas BioPharma, Inc. shareholders
As of Sep 30, 2026, 146 institutions reported holding Zenas BioPharma, Inc. Largest: Fidelity, Wellington and Sr One Capital Management, LP. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Value | As of |
|---|---|---|---|
| Fidelity | 9.79M | US$264M | Sep 30, 2026 |
| Wellington | 8.09M | US$218M | Sep 30, 2026 |
| Sr One Capital Management, LP | 5.04M | US$136M | Sep 30, 2026 |
| NEA Management Company, LLC | 4.02M | US$109M | Sep 30, 2026 |
| BlackRock | 3.33M | US$89.9M | Sep 30, 2026 |
| Federated Hermes, Inc. | 3.11M | US$83.8M | Sep 30, 2026 |
| Capital Group | 2.93M | US$78.9M | Sep 30, 2026 |
| Enavate Sciences Gp, LLC | 2.92M | US$78.7M | Sep 30, 2026 |
| Vanguard | 2.47M | US$66.5M | Sep 30, 2026 |
| Polar Capital Holdings Plc | 2.41M | US$64.9M | Sep 30, 2026 |
| Royalty Pharma Sub-Manager, LLC | 2.39M | US$64.4M | Sep 30, 2026 |
| Fairmount Funds Management LLC | 2.37M | US$64M | Sep 30, 2026 |
| State Street | 1.88M | US$50.8M | Sep 30, 2026 |
| Nvp Associates, LLC | 1.84M | US$49.6M | Sep 30, 2026 |
| T. Rowe Price | 1.09M | US$29.3M | Sep 30, 2026 |
| AllianceBernstein | 1.06M | US$28.6M | Sep 30, 2026 |
| Geode Capital | 1.06M | US$28.6M | Sep 30, 2026 |
| Two Sigma | 833K | US$22.5M | Sep 30, 2026 |
| EcoR1 Capital, LLC | 790K | US$21.3M | Sep 30, 2026 |
| Goldman Sachs | 775K | US$20.9M | Sep 30, 2026 |
| Bank of America | 683K | US$18.4M | Sep 30, 2026 |
| Candriam S.C.A. | 655K | US$17.7M | Sep 30, 2026 |
| Woodline Partners LP | 591K | US$15.9M | Sep 30, 2026 |
| ArrowMark Colorado Holdings LLC | 528K | US$14.2M | Sep 30, 2026 |
| Rock Springs Capital Management LP | 502K | US$13.5M | Sep 30, 2026 |
| Balyasny Asset Management L.P. | 491K | US$13.2M | Sep 30, 2026 |
| UBS | 474K | US$12.8M | Sep 30, 2026 |
| NEXTBio Capital Management LP | 427K | US$11.5M | Sep 30, 2026 |
| Vestal Point Capital, LP | 395K | US$10.7M | Sep 30, 2026 |
| Schwab | 383K | US$10.3M | Sep 30, 2026 |
| Northern Trust | 350K | US$9.45M | Sep 30, 2026 |
| BNP Paribas | 350K | US$9.44M | Sep 30, 2026 |
| Silverarc Capital Management, LLC | 334K | US$9.01M | Sep 30, 2026 |
| Barclays | 253K | US$6.81M | Sep 30, 2026 |
| Jennison Associates LLC | 242K | US$6.53M | Sep 30, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | 233K | US$6.29M | Sep 30, 2026 |
| Millennium | 194K | US$5.23M | Sep 30, 2026 |
| Morgan Stanley | 190K | US$5.12M | Sep 30, 2026 |
| Voleon Capital Management LP | 170K | US$4.58M | Sep 30, 2026 |
| Marshall Wace, LLP | 167K | US$4.5M | Sep 30, 2026 |
| Walleye Capital LLC | 120K | US$3.22M | Sep 30, 2026 |
| Invesco | 112K | US$3.01M | Sep 30, 2026 |
| Atom Investors LP | 111K | US$2.99M | Sep 30, 2026 |
| Seven Grand Managers, LLC | 100K | US$2.7M | Sep 30, 2026 |
| BNY | 99,186 | US$2.68M | Sep 30, 2026 |
| Point72 Asset Management, L.P. | 98,787 | US$2.66M | Sep 30, 2026 |
| Sio Capital Management, LLC | 95,457 | US$2.57M | Sep 30, 2026 |
| Birchview Capital, LP | 93,380 | US$2.52M | Sep 30, 2026 |
| Alps Advisors Inc | 86,369 | US$2.33M | Sep 30, 2026 |
| Jump Financial, LLC | 83,980 | US$2.26M | Sep 30, 2026 |
This page holds 50 of 146 holders.
Funds
This page holds 50 of 173 holders.
Big stakes
| Stake | Stake | Shares | Date | Filing |
|---|---|---|---|---|
| FMR LLC | 14.30% | 7.65M | Dec 31, 2025 | Schedule 13G |
| Wellington Management Group LLP | 12.40% | 8.09M | Sep 30, 2026 | Schedule 13G |
| InnoCare Pharma Inc. | 10.40% | 7M | Aug 26, 2026 | Schedule 13G |
| SR One Capital Management, LLC | 7.70% | 5.04M | Aug 13, 2026 | Schedule 13D |
| MOULDER LEON O JR | 5.09% | 3.22M | Apr 29, 2026 | Schedule 13D |
| BlackRock, Inc. | 5.00% | 3.29M | Sep 30, 2026 | Schedule 13G |
| Enavate Sciences Gp, LLC | 4.90% | 3.25M | Aug 19, 2026 | Schedule 13D |
| Patrick G. Enright | 4.90% | 2.63M | Oct 9, 2025 | Schedule 13D |